Reverse transcriptase/polymerase chain reaction follow-up and minimal residual disease detection in t(1;19)-positive acute lymphoblastic leukaemia

British Journal of Haematology

Volumn 92, Issue 3, 1996, Pages 653-658

  Privitera, Enrica ^a   Rivolta, Anna ^b   Ronchetti, Domenica ^b   Mosna, Giuliana ^b   Giudici, Giovanni ^b   Biondi, Andrea ^b  

^a Dipto Genet Biol Microrganismi   (Italy)

^b NONE

Author keywords

[No Author keywords available]

Indexed keywords

ACUTE LYMPHOBLASTIC LEUKEMIA; ARTICLE; CHILD; CHILDHOOD LEUKEMIA; CHROMOSOME TRANSLOCATION 1; CLINICAL ARTICLE; FEMALE; FOLLOW UP; HUMAN; MALE; MINIMAL RESIDUAL DISEASE; PRIORITY JOURNAL; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION;

ANTINEOPLASTIC AGENTS; BLOTTING, SOUTHERN; CHILD; CHILD, PRESCHOOL; CHIMERA; CHROMOSOMES, HUMAN, PAIR 1; CHROMOSOMES, HUMAN, PAIR 19; FEMALE; FOLLOW-UP STUDIES; HUMANS; KARYOTYPING; LEUKEMIA, LYMPHOCYTIC, ACUTE, L1; MALE; NEOPLASM, RESIDUAL; POLYMERASE CHAIN REACTION; RNA-DIRECTED DNA POLYMERASE; TRANSLOCATION, GENETIC;

EID: 0029986757     PISSN: 00071048     EISSN: None     Source Type: Journal    
DOI: 10.1046/j.1365-2141.1996.00366.x     Document Type: Article

References (33)

1. Bartram, C.R. (1993) Detection of minimal residual leukemia by the polymerase chain reaction: potential implications for therapy. Clinica Chimica Acta, 217, 75-78.
2. Brisco, M.J., Condon, J., Hughes, E., Neoh, S-H., Sykes, P.J., Seshadri, R., Toogood, I., Waters, K., Tauro, G., Ekert, H. & Morley, A.A. (1994) Outcome prediction in childhood acute lymphoblastic leukaemia by molecular quantification of residual disease at the end of induction. Lancet, 343, 196-200.
3. Biondi, A., Yokota, S., Hansen-Hagge, T.E., Rossi, V., Giudici, G., Maglia, O., Basso, G., Tell, C., Masera, G. & Bartram, C.R. (1992) Minimal residual disease in childhood acute lymphoblastic leukemia: analysis of patients in continuous complete remission or with consecutive relapse. Leukemia, 6, 282-288.
4. Campana, D. & Pui, C-H. (1995) Detection of minimal residual disease in acute leukemia: methodologic advances and clinical significance. Blood, 6, 1416-1434.
5. Conter, V., Arico, M., Valsecchi, M.G., Rizzari, C., Testi, A., Messina, C., Mori, P.G., Miniero, R., Colella, R., Basso, G., Rondelli, R., Pession, A. & Masera, G. (1995) Extended intrathecal methotrexate may replace cranial irradiation for prevention of CNS relapse in children with intermediate-risk acute lymphoblastic leukemia treated with BFM-based intensive chemotherapy. Journal of Clinical Oncology, 13, 2497-2502.
6. Crist, W.N., Carrol, A.J., Shuster, J.J., Behem, F.G., Whitehead, M., Vietti, T.J., Look, A.T., Mahoney, D., Ragab, A., Pullen, D.J. & Land, V.J. (1990) Poor prognosis of children with pre-B acute lymphoblastic leukemia is associated with the t(1;19)(q23:p13): a pediatric oncology group study. Blood, 76, 117-122.
7. Devaraj, P.E., Foroni, L., Sekhar, M., Butler, T., Wright, F., Mehta, A., Samson, D., Prentice, H.G., Hoffbrand, A.V. & Secker-Walker, L.M. (1994) E2A/HLF fusion cDNAs and the use of RT-PCR for the detection of minimal residual disease in t(17;19)(q22:p13) acute lymphoblastic leukemia. Leukemia, 8, 1131-1138.
8. Hunger, S.P., Galili, N., Carroll, A.J., Crist, W.M., Link, M.P. & Cleary, M.L. (1991) The t(1;19)(q23;p13) results in consistent fusion of E2A and PBX1 coding sequences in acute lymphoblastic leukemias. Blood, 77, 687-693.
9. Inaba, T., Roberts, W.M., Shapiro, L.H., Jolly, K.W., Raimondi, S.C., Smith, S.D. & Look, A.T. (1992) Fusion of the leucine zipper gene HLF to the E2A gene in human acute B-lineage leukemia. Science, 257, 531-534.
10. Ito, Y., Wasserman, R., Galili, N., Reichard, B.E., Shane, S., Lange, B. & Rovera, G. (1993) Molecular residual disease status at the end of chemotherapy fails to predict subsequent relapse in children with B-lineage acute lymphoblastic leukemia. Journal of Clinical Oncology, 11, 546-553.
11. Izraeli, S., Henn, T., Strobl, H., Ludwig, W-D., Kovar, H., Haas, O.A., Harbott, J., Bartram, C.R., Gadner, H. & Lion, T. (1993) Expression of identical E2A/PBX1 fusion transcripts occurs in both pre-B and early pre-B immunological subtypes of childhood acute lymphoblastic leukemia. Leukemia, 7, 2054-2056.
12. Izraeli, S., Kovar, H., Gadner, H. & Lion, T. (1992) Unexpected heterogeneity in E2A/PBX1 fusion messenger RNA detected by the polymerase chain reaction in pediatric patients with acute lymphoblastic leukemia. Blood, 80, 1413-1417.
13. Kamps, M.P., Look, A.T. & Baltimore, D. (1991) The human t(1;19) translocation in pre-B ALL produces multiple nuclear E2A-Pbx1 fusion proteins with differing transforming potentials. Genes and Development, 5, 358-368.
14. Kamps, M.P., Murre, C., Sun, X. & Baltimore, D. (1990) A new homeobox gene contributes the DNA binding domain of the t(1;19) translocation protein in pre-B ALL. Cell, 60, 547-555.
15. Kusec, R., Laczika, K., Knobl, P., Fiedl, J., Greinix, H., Kahls, P., Linkesch, W., Schwarzinger, I., Mitterbauer, G., Purtscher, B., Haas, O.A., Lechner, K. & Jaeger, U. (1994) AML1/ETO fusion mRNA can be detected in remission blood samples of all patients with t(8;21) acute myeloid leukemia after chemotherapy or autologous bone marrow transplantation. Leukemia, 8, 735-739.
16. Nizet, Y., Van Daele, S., Lewalle, P., Vaerman, J.L., Philippe, M., Vermylen, C., Cornu, G., Ferrant, A., Michaux, J.L. & Martiat, P. (1993) Long-term follow-up of residual disease in acute lymphoblastic leukemia patients in complete remission using clonogeneic IgH probes and the polymerase chain reaction. Blood, 82, 1618-1625.
17. Nourse, J., Mellentin, J.D. Galili, N., Wilkinson, J., Stanbridge, E., Smith, S.D. & Cleary, M.L. (1990) Chromosomal translocation t(1;19) results in synthesis of a homeobox fusion mRNA that codes for a potential chimaeric transcription factor. Cell, 60, 535-545.
18. Nucifora, G., Larson, R.A. & Rowley, J.D. (1993) Persistance of the 8;21 translocation in patients with acute myeloid leukemia type M2 in long-term remission. Blood, 82, 712-715.
19. Numata, S., Kato, K. & Horibe, K. (1993) New E2A/PBX1 fusion transcript in a patient with t(1;19)(q23;p13) acute lymphoblastic leukemia. Leukemia, 7, 1441-1444.
20. Peverali, F.A., Ramquist, T., Saffrich, R., Pepperkok, R., Barone, M.V. & Philipson, L. (1994) Regulation of G1 expression by E2A and 1d helix-loop-helix proteins. EMBO Journal, 13, 4291-4301.
21. Potter, M.N., Steward, C.G. & Oakhill, A. (1993) The significance of detection of minimal residual disease in childhood acute lymphoblastic leukaemia. British Journal of Haematology, 83, 412-418.
22. Privitera, E., Kamps, M.P., Hayashi, Y., Inaba, T., Shapiro, L.H., Raimondi, S.C., Behm, F., Hendershot, L., Carroll, A.J., Baltimore, D. & Look, A.T. (1992) Different molecular consequences of the 1;19 chromosomal translocation in childhood B-cell precursor acute lymphoblastic leukemia. Blood, 79, 1781-1788.
23. Privitera, E., Luciano, A., Ronchetti, D., Aricò, M., Santostasi, T., Basso, G. & Biondi, A. (1994) Molecular variants of the 1;19 chromosomal translocation in pediatric acute lymphoblastic leukemia (ALL). Leukemia, 8, 554-559.
24. Pui, C-H., Raimondi, S.C., Hancock, M.L., Rivera, G.K., Ribeiro, R.C., Mahmoud, H.H., Sandlund, J.T., Crist, W.M. & Behm, F.G. (1994) Immunologic, cytogenetic ad clinical characterization of childhood acute lymphoblastic leukemia with the t(1;19)(q23:p13) or its derivative. Journal of Clinical Oncology, 12, 2601-2606.
25. Raimondi, S.C. (1993) Current status of cytogenelic research in childhood acute lymphoblastic leukemia. Blood, 81, 2237-2251.
26. Raimondi, S.C., Behm, F.G., Roberson, P.K., Pui, C-H., Williams, D.L., Crist, W.M., Look, A.T. & Rivera, G.K. (1990) Cytogenetics of pre-B-cell acute lymphoblaslic leukemia with emphasis on prognostic implications of the T(1;19). Journal of Clinical Oncology, 8, 1380-1388.
27. Riehm, H., Gadner, H., Heze. G., Kornhuber, B., Lampert, F., Niehammer, D., Rieter, A. & Scheuong, G. (1990) Results and significance of six randomized trials in four consecutive ALL-BFM studies. Haematologie und Bluttransfusion, 33, 439-450.
28. Rivera, G.K., Raimondi, S.C., Hancock, M.L., Behm, F.G., Pui, C-H., Abramovtch, M., Minno, J.J.R., Ochs, J., Look, A.T., Williams, D.L., Murphy, S.B., Dhal, G.V., Kalwinsky, D.K., Evans, W.E., Kun, L.E., Simone, J.V. & Crist, W.M. (1991) Improved outcome in childhood acute lymphoblastic leukaemia with reinforced early treatment and rotational combination chemotherapy. Lancet, 337, 61-65.
29. Schlissel, M., Voronova, A. & Baltimore, D. (1991) Helix-loop-helix transcription factor E47 activates germ-line immunoglobulin heavy-chain gene transcription and rearrangement in a pre-T-cell line. Genes and Development, 5, 1367-1376.
30. Troussard, X., Rimokii, R., Valensi, H., Leboeuf, D., Fenneteau, O., Guitard, A-M., Manel, A-M., Schillinger, F., Leglise, C., Brizard, A., Gardais, J., Lessard, M., Flandrin, G. & Macintyre, E. (1995) Heterogeneity of t(1;19)(q23;p13) acute leukaemias. British Journal of Haematology, 89, 516-526.
31. Van der Does-van den Berg, A., Bartram, C.R., Basso, G., Benoit, Y.C.M., Biondi, A., Debatin, K-M, Haas, O.A., Harbott, J., Kamps, W.A., Kouer, U., Lampert, F., Ludwig, W-D., Niemeyer, C.M. & Van Wering, E.R. (1992) Minimal requirements for the diagnosis, classification and evaluation of the treatment of childhood acute lymphoblastic leukemia (ALL) in the 'BFM family' cooperative group. Medical and Pediatric Oncology, 20, 497-505.
32. Wasserman, R., Galili, N., Ito, Y., Silber, J.H., Reichard, B.A., Shane, S., Womer, R.B., Lange, B. & Rovera, G. (1992) Residual disease at the end of the induction therapy as a predictor of relapse during therapy in childhood B-lineage acute lymphoblastic leukemia. Journal of Clinical Oncology, 10, 1879-1888.
33. Williams, D.L., Harris, A., Williams, K.J., Brosius, M.J. & Lemonds, W. (1984) Direct bone marrow chromosome technique for acute lymphoblastic leukemia. Cancer Genetics and Cytogenetics, 13, 239-257.